Health & Fitness
Health and Fitness
Health and Fitness
Mon, September 13, 2010
Sun, September 12, 2010
Fri, September 10, 2010
SoCalBio Investor & Partnership Conference Keynote to be Delivered by Bioscience Industry Veteran Perry Karsen
LOS ANGELES--([ BUSINESS WIRE ])--The Southern California Biomedical Council (SoCalBio) is pleased to announce that Perry Karsen - chief operations officer of Celgene Corporation (NASDAQ: CELG) - will deliver the keynote address at the 12th Annual SoCalBio Investor & Partnership Conference, which will be held Thursday, November 4th at the J W Marriott of L.A. Live in downtown Los Angeles.
"His achievements and breadth of experience in venture capital, M&A and licensing for both large and small life science companies make him uniquely qualified to discuss how Los Angeles-area biomedical entrepreneurs can succeed."
Mr. Karsen's keynote will focus on collaboration trends during and following the current economic downturn. It will target executives at emerging medical device, biotechnology and healthcare informatics firms by building on this year's conference theme: "Sustaining Innovation in a Challenging Economy."
Most recently, Mr. Karsen served as president and CEO of Pearl Therapeutics, which develops double and triple combination therapies for highly prevalent respiratory diseases. From 2004-2009, he served as senior vice president and head of worldwide business development for Celgene Corporation (his current employer), where he was also president of the Asia/Pacific Region. Prior to joining Celgene, he was senior vice president of business development at Human Genome Sciences (NASDAQ: HGSI).
Earlier in his career, Mr. Karsen served as vice president of strategic business analysis and development at Bristol-Myers Squibb (NYSE: BMY); senior vice president of marketing at Zimmer, Inc. (NYSE and SIX: ZMH); and director of business development and representative director, Japan at Genentech (SIX: RO, ROG; OTCQX: RHHBY). He also worked in various domestic and international roles with Abbott Laboratories (NYSE: ABT), and was a general partner at Pequot Ventures, where he was responsible for early and late stage investments in biotechnology and medical device firms.
Mr. Karsen earned a Masters of Management degree from Northwestern Universitya™s Kellogg Graduate School of Management, a Masters in Teaching of Biology from Duke University, and a B.S. in Biological Sciences from the University of Illinois, Urbana.
aWe are thrilled that Mr. Karsen will keynote this year's SoCalBio Conference,a said Stephen Williams, PhD, president of retained executive search firm Bench International, and chairman of the SoCalBio Conference Speaker Selection Subcommittee. aHis achievements and breadth of experience in venture capital, M&A and licensing for both large and small life science companies make him uniquely qualified to discuss how Los Angeles-area biomedical entrepreneurs can succeed.a
SoCalBio President Ahmed Enany added, aIn addition to his exceptional background, Mr. Karsen was selected to keynote this year's Conference because he represents a global biotechnology company on its way to becoming a corporate citizen of Los Angeles by virtue of its proposed acquisition of Abraxis Bioscience."
The SoCalBio Investor and Partnership Conference is the only annual event of its kind in the Los Angeles region. The 40 companies selected to present at this yeara™s conference are focused on a wide range of technologies and market segments, including regenerative medicine, therapeutic devices, bio-pharmaceuticals, molecular imaging, biosensors and personalized medicine.
In addition to emerging company and keynote presentations, the Conference features breakout sessions that engage attendees in discussions about how local companies can expedite capital/partnership formation while positioning themselves for growth when the economy rebounds.
For more information about the Conference, including a detailed agenda, please visit [ www.socalbio.org ].
Conference Sponsors:
The 12th SoCalBio Investor & Partnership Conference is sponsored by companies and organizations dedicated to helping grow the life-science industry in the greater Los Angeles region. SoCalBio is especially grateful to the following lead sponsors:
- Ernst & Young LLP [ http://www.ey.com ]
- Perkins Coie LLP [ http://www.perkinscoie.com ]
About the Southern California Biomedical Council (SoCalBio):
The Southern California Biomedical Council is a nonprofit, member-supported trade association that fosters medical device, IVD, health informatics and biotech R&D, manufacturing, job creation and overall economic growth in the six counties (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino) that comprise the Greater Los Angeles region.
The Councila™s programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policy makers and the public at-large about the benefits of the regiona™s life-science industry. The annual SoCalBio Investor & Partnership Conference has grown to become the regiona™s largest showcase for emerging life-science companies and technologies.
SoCalBio is open to membership by local firms and organizations engaged in life-science technology development and commercialization. More information is available at [ www.SoCalBio.org ].
Connect with SoCalBio at:
